首页|期刊导航|癌症生物学与医学(英文版)|Less is more:patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies

Less is more:patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapiesOA

Less is more:patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies

Bohao Zheng;Dian Fan;Shengtao Zhou

Department of Obstetrics and Gynecology,Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education and State Key Laboratory of Biotherapy,West China Second Hospital,Sichuan University and Collaborative Innovation Center,Chengdu 610000,China||Wuxi School of Medicine,Jiangnan University,Wuxi 214000,ChinaDepartment of Obstetrics and Gynecology,Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education and State Key Laboratory of Biotherapy,West China Second Hospital,Sichuan University and Collaborative Innovation Center,Chengdu 610000,ChinaDepartment of Obstetrics and Gynecology,Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education and State Key Laboratory of Biotherapy,West China Second Hospital,Sichuan University and Collaborative Innovation Center,Chengdu 610000,China

《癌症生物学与医学(英文版)》 2026 (8)

1051-1056,6

10.20892/j.issn.2095-3941.2026.0139

评论